Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2300087	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	Supplementary Application	2023-05-09					view
JYSB2300066	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	Supplementary Application	2023-04-14					view
JYSB2300065	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	Supplementary Application	2023-04-14					view
JYSB2300015	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	Supplementary Application	2023-02-03					view
CXSS2300004	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(3.3)	New Drug Application	2023-01-29		QILU Pharmaceutical Co Ltd			view
JYSB2200118	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	Supplementary Application	2022-07-07					view
JYSZ2200031	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	License Renew	2022-07-06					view
JXSL2200083	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(3.3)	Import Drug Application	2022-06-13					view
JXSL2101039	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(2.1)	Import Drug Application	2021-06-07					view
JYSZ2100514	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	License Renew	2021-05-10					view
CXSL2101029	重组抗VEGF人源化单克隆抗体Fab片段注射液	Ranibizumab	Injection	Biological Products(3.3)	New Drug Application	2021-04-21		Jecho Biopharmaceuticals Co Ltd			view
JXSS2000044	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(3.1)	Import Drug Application	2020-10-14	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2021-08-17	view
JXSS2000047	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(3.1)	Import Drug Application	2020-10-14	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2021-08-17	view
JXSS2000046	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(3.1)	Import Drug Application	2020-10-14	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2021-08-17	view
JXSS2000045	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(3.1)	Import Drug Application	2020-10-14	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2021-08-17	view
JXSS2000038	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(3.1)	Import Drug Application	2020-10-10	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2021-08-17	view
JXSL2000131	雷珠单抗注射液	Ranibizumab	Injection	Biological Products(3.3)	Import Drug Application	2020-07-17	上海艾迈医疗科技有限公司	7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited	In Review	2020-07-16	view
JYSB2000311	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	Supplementary Application	2020-06-24	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Filed	2020-06-24	view
JYSB2000301	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	Supplementary Application	2020-06-22	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Filed	2020-06-24	view
JXSL2000080	雷珠单抗注射液	Ranibizumab	Injection	Biological Products	Import Drug Application	2020-06-22	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	In Review	2020-06-20	view